Ha habido 50 transacciones internas recientes registradas para Cue Biopharma, Inc. (CUE), incluyendo 44 compras y 0 ventas. El total de compras internas fue valorado en $7.56M y el total de ventas internas en RSU Award.
Internos destacados con actividad reciente incluyen Broadfoot Jill Marie, Kiener Peter A, Morich Frank. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — CUE
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-01-02 |
Broadfoot Jill Marie |
Director |
Concesión de RSU |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Kiener Peter A |
Director |
Concesión de RSU |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Morich Frank |
Director |
Concesión de RSU |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Verheyen Patrick |
Director |
Concesión de RSU |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Garzone Pamela |
Director |
Concesión de RSU |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Sarraf Pasha |
Director |
Concesión de RSU |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2025-12-30 |
Sarraf Pasha |
Director |
Compra Informativa |
4,229 |
$0.31 |
$1.31K |
4,229 |
| 2025-12-03 |
Sandercock Colin |
SVP, General Counsel |
Concesión de RSU |
70,000 |
$0.70 |
$49K |
70,000 |
| 2025-09-29 |
Azam Usman |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-09-29 |
Azam Usman |
Chief Executive Officer |
Concesión de RSU |
1,875,000 |
$0.72 |
$1.35M |
1,875,000 |
| 2025-09-29 |
Warren Lucinda |
Chief Business Officer |
Concesión de RSU |
125,000 |
$0.72 |
$90K |
125,000 |
| 2025-09-29 |
Baker Daniel G. |
Chief Development Officer |
Concesión de RSU |
50,000 |
$0.72 |
$36K |
50,000 |
| 2025-09-26 |
Sandercock Colin |
SVP, General Counsel |
Concesión de RSU |
30,000 |
$0.70 |
$21K |
30,000 |
| 2025-06-04 |
Broadfoot Jill Marie |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-06-04 |
Broadfoot Jill Marie |
Director |
Concesión de RSU |
48,800 |
$0.62 |
$30.26K |
48,800 |
| 2025-03-21 |
Passeri Daniel R |
Chief Executive Officer |
Concesión de RSU |
450,000 |
$0.99 |
$445.5K |
450,000 |
| 2025-03-21 |
Sandercock Colin |
SVP, General Counsel |
Concesión de RSU |
200,000 |
$0.99 |
$198K |
200,000 |
| 2025-03-21 |
Millar Kerri-ann |
Chief Financial Officer |
Concesión de RSU |
200,000 |
$0.99 |
$198K |
200,000 |
| 2025-03-21 |
Levisetti Matteo |
Chief Medical Officer |
Concesión de RSU |
250,000 |
$0.99 |
$247.5K |
250,000 |
| 2025-03-21 |
Warren Lucinda |
Chief Business Officer |
Concesión de RSU |
250,000 |
$0.99 |
$247.5K |
250,000 |
| 2025-03-21 |
Baker Daniel G. |
Chief Development Officer |
Concesión de RSU |
100,000 |
$0.99 |
$99K |
100,000 |
| 2025-03-10 |
Sarraf Pasha |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-03-10 |
Sarraf Pasha |
Director |
Concesión de RSU |
48,800 |
$1.03 |
$50.26K |
48,800 |
| 2025-01-02 |
Driscoll Frederick W |
Director |
Concesión de RSU |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Kiener Peter A |
Director |
Concesión de RSU |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Morich Frank |
Director |
Concesión de RSU |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Verheyen Patrick |
Director |
Concesión de RSU |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Garzone Pamela |
Director |
Concesión de RSU |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2024-12-16 |
Passeri Daniel R |
Chief Executive Officer |
Compra Informativa |
30,000 |
$1.03 |
$30.9K |
164,578 |
| 2024-11-25 |
Baker Daniel G. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-11-25 |
Baker Daniel G. |
Chief Development Officer |
Concesión de RSU |
200,000 |
$1.06 |
$212K |
200,000 |
| 2024-09-03 |
Warren Lucinda |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-09-03 |
Warren Lucinda |
Chief Business Officer |
Concesión de RSU |
350,000 |
$0.66 |
$231K |
350,000 |
| 2024-06-05 |
Fox Michael J |
Director |
Desconocido |
- |
- |
- |
100,000 |
| 2024-06-05 |
Fox Michael J |
Director |
Concesión de RSU |
48,800 |
$1.65 |
$80.52K |
48,800 |
| 2024-06-05 |
Sandercock Colin |
SVP, General Counsel |
Concesión de RSU |
60,000 |
$1.65 |
$99K |
60,000 |
| 2024-06-05 |
Millar Kerri-ann |
Chief Financial Officer |
Concesión de RSU |
60,000 |
$1.65 |
$99K |
60,000 |
| 2024-06-05 |
Suri Anish |
President and CSO |
Concesión de RSU |
150,000 |
$1.65 |
$247.5K |
150,000 |
| 2024-06-05 |
Levisetti Matteo |
Chief Medical Officer |
Concesión de RSU |
125,000 |
$1.65 |
$206.25K |
125,000 |
| 2024-03-06 |
Passeri Daniel R |
Chief Executive Officer |
Concesión de RSU |
400,000 |
$1.94 |
$776K |
400,000 |
| 2024-03-06 |
Sandercock Colin |
SVP, General Counsel |
Concesión de RSU |
175,000 |
$1.94 |
$339.5K |
175,000 |
| 2024-03-06 |
Millar Kerri-ann |
Chief Financial Officer |
Concesión de RSU |
250,000 |
$1.94 |
$485K |
250,000 |
| 2024-03-06 |
Suri Anish |
President and CSO |
Concesión de RSU |
300,000 |
$1.94 |
$582K |
300,000 |
| 2024-03-06 |
Levisetti Matteo |
Chief Medical Officer |
Concesión de RSU |
260,000 |
$1.94 |
$504.4K |
260,000 |
| 2024-02-20 |
Levisetti Matteo |
Chief Medical Officer |
Concesión de RSU |
25,000 |
$3.36 |
$84K |
25,000 |
| 2024-01-02 |
Driscoll Frederick W |
Director |
Concesión de RSU |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Kiener Peter A |
Director |
Concesión de RSU |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Morich Frank |
Director |
Concesión de RSU |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Verheyen Patrick |
Director |
Concesión de RSU |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Garzone Pamela |
Director |
Concesión de RSU |
24,400 |
$2.78 |
$67.83K |
24,400 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
